Target intelligence / Profile preview

Extra Domain-B Splice Variant of Fibronectin (EDB-FN)

Target
EDB-FN
Molecular classification
Extracellular matrix glycoprotein, Splice variant
01

Overview

The extra domain B splice variant of fibronectin (EDB+FN) is an alternatively spliced form of the fibronectin glycoprotein, a major component of the extracellular matrix (ECM). EDB+FN contains a 91-amino acid type III domain inserted between domains 7 and 8. It is highly expressed in the ECM of neovascularized tissues and malignant tumors, but its expression in normal adult tissues is low or absent. EDB+FN plays key roles in tumor growth, angiogenesis, and tumor invasion, making it an attractive target for drug delivery systems and antibody-drug conjugates (ADCs).

Other names
EDB+FNFibronectin EDB splice variantOncofetal fibronectin
02

Mechanism of action

Payload release into the tumor microenvironment leading to direct cytotoxicity and enhanced immune cell infiltration. Bystander effect due to extracellular proteolytic cleavage near/in tumor stroma.

03

Biological functions

AngiogenesisTumor growthTumor invasionTissue remodeling
04

Disease associations

CancerWound healing
05

Safety considerations

Potential for off-target effects, although preclinical studies show minimal toxicity to normal tissuesImmunogenicity of ADCsTumor heterogeneity in EDB+FN expression
06

Interacting drugs

Antibody-drug conjugates (ADCs) targeting EDB+FN

3 more in the full profile.

07

Biomarkers

EDB+FN expression levels in tumor tissueHigh tumoral EDB expression correlates with poor prognosis in gliomas

Beyond the preview

Go deeper on Extra Domain-B Splice Variant of Fibronectin (EDB-FN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extra Domain-B Splice Variant of Fibronectin (EDB-FN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call